Two India Drug Makers Get U.S. FDA Warning Letters For Violations
This article was originally published in PharmAsia News
Executive Summary
India's Canton Laboratories Private, a supplier of active pharmaceutical ingredients for major drug makers, received a U.S. FDA warning for alleged forgery of test results and unclean equipment.